References
- Im HG, Yu MH, Chung DW, Lee IS. 2006. Inhibitory effect of fungal metabolites isolated from foodstuffs on the growth of human cancer cell lines. Korean J Food Sci Technol 38: 262-267
- Shin YJ, Jung DY, Ha HK, Park SW. 2004. Anticancer effect of Erythronium japonicum extract on ICR mouse and L1210 cells with alteration of antioxidant enzyme activities. Korean J Food Sci Technol 36: 968-973
- Astrow AB. 1994. Rethinking cancer. Lancet 343: 494-503 https://doi.org/10.1016/S0140-6736(94)91454-0
- Bailer JC, Gormick HL. 1997. Cancer undefeated. N Eng J med 336: 1567-1575
- Garcia-Fernandez LF, Reyes F, Sanchez-Puelles JM. 2002. The marine pharmacy: new antitumoral compounds from the sea. Pharm News 9: 495-501 https://doi.org/10.1080/713743131
- Amador ML, Jimeno J, Paz-Ares L, Cortes-Funes H, Hidalgo M. 2003. Progress in the development and acquisition of anticancer agents from marine sources. Ann Oncol 14: 1607-1615 https://doi.org/10.1093/annonc/mdg443
- Lee EH, Chung SK, Jeon JK, Cha YJ, Chung SY. 1983. A study on the taste compounds of an ascidian, Styela plicata. Korean J Food Sci Technol 15: 1-5
- Tincu JA, Menzel LP, Azimov R, Sands J, Hong T, Waring AJ, Tayor SW, Lehrer RI. 2003. Plicatamide, an antimicrobial octapeptide from Styela plicata hemocyte. J Biol Chem 278: 13546-13553 https://doi.org/10.1074/jbc.M211332200
- Tincu JA, Taylor SW. 2004. Antimicrobial peptides from marine invertebrates. Antimicrob Agents Chemother 48: 3645-3654 https://doi.org/10.1128/AAC.48.10.3645-3654.2004
- Cardilo-Reis L, Cavalcante MC, Silveira CB, Pavao MS. 2006. In vivo antithrombotic properties of a heparin from the oocyte test cells of the sea squirt Styela plicata (Chordata-Tunicata). Braz J Med Biol Res 39: 1409-1415 https://doi.org/10.1590/S0100-879X2006001100004
- Cavalcante MC, Allodi S, Valente AP, Straus AH, Takahashi HK, Mourao PA, Pavao MS. 2000. Occurrence of heparin in the invertebrate Styela plicata (Tunicata) is restricted to cell layers facing the outside environment. J Biol Chem 275: 36189-36196 https://doi.org/10.1074/jbc.M005830200
- Wang R, Duan WJ, Zhang X, Zeng FL, Wan XX. 2006. Antiviral treatment of hepatitis B virus-transgenic mice by a marine organism, Styela plicata. World J Gastroenterol 12: 4038-4043 https://doi.org/10.3748/wjg.v12.i25.4038
- Kim JJ, Kim SJ, Kim SH, Park HR, Lee SC. 2005. Antioxidnat and anticancer activities of extracts from Styela plicata. J Korean Soc Food Sci Nutr 34: 937-941 https://doi.org/10.3746/jkfn.2005.34.7.937
- Mayer AM, Custafson KR. 2003. Marine pharmacology in 2000: antitumor and cytotoxic compounds. Int J Cancer 105: 291-299 https://doi.org/10.1002/ijc.11080
- Jimeno J, Faircloth G, Sousa-Faro JMF, Scheuer P, Rinehart K. 2004. New marine derived anticancer therapeutics - a journey from the sea to clinical trials. Mar Drugs 2: 14-29 https://doi.org/10.3390/md201014
- Fish B. 1984. Clinical trials for the evaluation of cancer therapy. Cancer Res 54: 609-615
- Goodman GY, Yen YP, Cox TC, Crowlny J. 1987. Effect of verapamil on in vitro cytotoxicity of adriamycin and vinblastine in human tumor cells. Cancer Res 47: 2295-2311
- SAS Institute. 1995. SAS/STAT User's Guide. SAS Institute Inc., Cary, NC, USA
- Raftos DA, Hutchinson A. 1995. Cytotoxicity reactions in the solitary tunicate Styela plicata. Dev Comp Immunol 19: 463-471 https://doi.org/10.1016/0145-305X(95)00028-R
- Cammarata M, Arizza V, Parrinello N, Candore G, Caruso C. 1997. Phenoloxidase-dependent cytotoxic mechanism in ascidian (Styela plicata) hemocytes active against erythrocytes and K562 tumor cells. Eur J Cell Biol 74: 302-307
- Lee EH, Oh KS, Lee TH, Ahn CB, Chung YH, Kim KS. 1985. Lipid components of sea squirt, Halocynthia roretzi, and mideuduck, Styela clava. Korean J Food Sci Technol 17: 289-294
- Siddiqui RA, Zerouga M, Wu M, Castillo A, Harvey K, Zaloga GP, Stillwell W. 2005. Anticancer properties of propofol-docosahexaenoate and propofol-eicosapentaenoate on breast cancer cells. Breast Cancer Res 7: 645-654 https://doi.org/10.1186/bcr1036.
- Palakurthi SS, Fluckiger R, Aktas H, Changolkar AK, Shahdafaei A, Harneit S, Kilic E, Halperin JA. 2000. Inhibition of translation initiation mediates the anticancer effect of the n-3 polyunsaturated fatty acid eicosapentaenoic acid. Cancer Res 60: 2919-2925
- Chi TY, Chen GG, Lai PB. 2004. Eicosapentaenoic acid induces Fas-mediated apoptosis through a p53-dependent pathway in hepatoma cells. Cancer J 10: 190-200 https://doi.org/10.1097/00130404-200405000-00009
Cited by
- Antioxidant and Antihypertensive Activities of Styela plicata according to Harvesting Time and Size vol.40, pp.3, 2011, https://doi.org/10.3746/jkfn.2011.40.3.350